Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.280
-0.110 (-4.60%)
At close: May 15, 2026, 4:00 PM EDT
2.320
+0.040 (1.75%)
After-hours: May 15, 2026, 7:51 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $164.68 million as of May 15, 2026. Its market cap has increased by 156.11% in one year.
Market Cap
164.68M
Enterprise Value
75.27M
1-Year Change
156.11%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $164.68M, a decrease of -73.37%. That is a compound annual growth rate of -23.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 144.14M | 12.78% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.78% |
| Dec 30, 2022 | 220.66M | -19.35% |
| Dec 31, 2021 | 273.60M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 185.05M |
| Enlivex | 176.50M |
| ProQR Therapeutics | 173.85M |
| Heron Therapeutics | 172.70M |
| Immunic | 172.38M |
| AN2 Therapeutics | 167.02M |
| Black Diamond Therapeutics | 163.88M |
| Equillium | 163.76M |